Conference report: Belgian consensus on metabolic problems associated with atypical antpsychotics;Troubles métaboliques associés aux antipsychotiques atypiques: consensus belge sur la conduite à tenir

Encephale

Volumn 33, Issue 2, 2007, Pages 197-202

  De Nayer, A ^a   De Hert, M ^b   Scheen, A ^b   Van Gaal, L ^c   Peuskens, J ^b  

^a Hôpital Sainte Thérèse IFAC   (Belgium)

^b Clinique Sint Jozef

^c Metabolism and Nutrition ^*  (Belgium)

Author keywords

Diabetus mellitus; Metabolic syndrom; Prevention; Schizophrenia; Second generation atypics

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; GLUCOSE; HALOPERIDOL; INSULIN; OLANZAPINE; QUETIAPINE; RISPERIDONE; TRIACYLGLYCEROL; ZIPRASIDONE;

DIABETOGENESIS; DISEASE EXACERBATION; GLUCOSE METABOLISM; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MEDICAL LITERATURE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN;

EID: 34249076554     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0013-7006(07)91550-x     Document Type: Review

References (32)

1. AMERICAN DIABETES ASSOCIATION. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2002 ; 26 (Suppl 1) : 33-50.
2. CARO JJ, WARD A, LEVINTON C et al. The risk of diabetes during olanzapine use compared with risperidone use : a retrospective database analysis. J Clin Psychiatry 2002 ; 63 : 1135-9.
3. CITROME LL, JAFFE AB. Relationship of atypical antipsychotics with development of diabetes mellitus. Ann Pharmacother 2003 ; 37 : 1849-57.
4. CLARK C, BURGE MR. Diabetes mellitus associated with atypical antipsychotic medications. Diabetes Technol Ther 2003 ; 5 : 669-83.
5. COHN T, WOLEVER T, ZIPURSKY R et al. Screening for diabetes and impaired glucose tolerance in patients on antipsychotic medication. J Neuropsychopharmacol 2002 ; 5 (Suppl I) : 168.
6. CONSENSUS DEVELOPMENT CONFERENCE ON ANTIPSYCHOTIC DRUGS AND OBESITY AND DIABETES. Diabetes Care 2004 ; 27 : 596-601.
7. DE HERT M, VAN EYCK D, PEUSKENS H et al. Prevalence of impaired glucose tolerance in schizophrenic patients [abstract]. Annual Meeting of the American Psychiatric Society, 2004.
8. GIANFRANCESCO FD, GROGG AL, MAHMOUD RA et al. Differential effects of risperidone, olanzapine, clozapine and conventional antipsychotics on type 2 diabetes : findings from a large health plan database. J Clin Psychiatry 2002 ; 63 : 920-30.
9. GIANFRANCESCO F, GROGG A, MAHMOUD R et al. Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders. Clin Ther 2003 ; 25 : 1150-71.
10. GOUGH S, PELEVER R. Diabetes and its prevention : pragmatic solutions for people with schizophrenia. Br J Psychiatry 2004 ; 184 : S106-S111.
11. GUERY C. Schizophrénie, diabète et antipsychotique. Encephale 2004 ; 30 (4) : 382-91.
12. HAUPT DW, NEWCOMER JW. Hyperglycemia and antipsychotic medications. J Clin Psychiatry 2001 ; 62 (Suppl 27) : 15-26 ; discussion : 40-1.
13. HEDENMALM K, HAGG S, STAHL M et al. Glucose intolerance with atypical antipsychotics. Drug Saf 2002 ; 25 : 1107-16.
14. HENDERSON DC. Atypical antipsychotic-induced diabetes mellitus : how strong is the evidence ? CNS Drugs 2002 ; 16 : 77-89.
15. HOWES OD, BHATNAGAR, FP GAUGHRAN et al. The effect of clozapine on factors controlling glucose homeostasis. Clin Neuropsychopharmacol S67 ; poster APA 2005.
16. KNOWLER WC, BARRETT-CONNOR E, FOWLER SE et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 ; 346 : 393-403.
17. KOLLER EA, CROSS JT, DORAISWAMY PM et al. Risperidone-associated diabetes mellitus : a pharmacovigilance study. Pharmacotherapy 2003 ; 23 : 735-44.
18. KOLLER EA, DORAISWAMY PM. Olanzapine-associated diabetes mellitus. Pharmacotherapy 2002 ; 22 : 841-52.
19. KOLLER E, SCHNEIDER B, BENNETT K et al. Clozapine-associated diabetes. Am J Med 2001 ; 111 : 716-23.
20. KOLLER EA, WEBER J, DORAISWAMY PM et al. A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus. J Clin Psychiatry 2004 ; 65 : 857-63.
21. KORO CE, FEDDER DO, L'ITALIEN GJ et al. Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia : population based nested casecontrol study. Br Med J 2002 ; 325 : 243.
22. MARDER SR, ESSOCK SM, MILLER AL et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry 2004 ; 161 : 1334-49.
23. MELKERSSON K, DAHL ML. Adverse metabolic effects associated with atypical antipsychotics : literature review and clinical implications. Drugs 2004 ; 64 : 701-23.
24. MEYER JM, KORO CE. The effects of antipsychotic therapy on serum lipids : a comprehensive review. Schizophr Res 2004 ; 70 : 1-17.
25. MUKHERJEE S, DECINA P, BOCOLA V et al. Diabetes mellitus in schizophrenic patients. Compr Psychiatry 1996 ; 37 : 68-73.
26. NASRALLAH HA, KORN ML. Metabolic disorders in schizophrenia : relationship to atypical antipsychotic treatment. Posted 07/28/2004 : Medscape Psychiatry and Mental Health Schizophrenia Expert Column, 2004.
27. PALMER JP, HIRSCH IB. What's in a name : latent auto-immune diabetes of adults, type 1.5, adult-onset, and type 1 diabetes. Diabet Care 2003 ; 26 : 536-8.
28. REGENOLD WT, THAPAR RK, MARANO C et al. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 2002 ; 70 : 19-26.
29. ROSACK J. FDA to require diabetes warning on antipsychotics. Psychiatr News 2003 ; 38 : 1-a-27.
30. «SCHIZOPHRENIA AND DIABETES 2003». Expert Consensus Meeting, Dublin, 3-4 October 2003 : consensus summary. Br J Psychiatry 2004 ; 184 : S112-4.
31. SERNYAK MJ, LESLIE DL, ALARCON RD et al. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry 2002 ; 159 : 561-6.
32. SUBRAMANIAM M, CHONG SA, PEK E. Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia. Can J Psychiatry 2003 ; 48 : 345-7.